Atlas Trials

BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity

Clinical trial NCT07622810 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07622810
Sponsor
Carnot Laboratories
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Obesity & Overweight
Start date
2026-09-01
Primary completion
2027-12-01
Enrollment
352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.